BANK VONTOBEL/PUT/EDWARDS LIFESCIENCES/95/0.1/20.12.24 | Real-time Bid/Ask 04:44:02 2024-07-17 am EDT | ||
| 0.96 EUR / 1.01 EUR | +18.67% |
|
| Current month | +20.29% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
| Date | Price | Change |
|---|---|---|
| 24-07-17 | 0.94 | +13.25% |
| 24-07-16 | 0.83 | +10.67% |
| 24-07-15 | 0.75 | +10.29% |
| 24-07-12 | 0.68 | +6.25% |
| 24-07-11 | 0.64 | -1.54% |
Delayed Quote Börse Stuttgart
Last update July 17, 2024 at 02:18 am EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Vontobel
|
| WKN | VD8M1D |
| ISIN | DE000VD8M1D4 |
| Date issued | 2024-06-24 |
| Strike | 95 $ |
| Maturity | 2024-12-20 (157 Days) |
| Parity | 10 : 1 |
| Emission price | 0.81 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.94 € |
|---|---|
| Lowest since issue | 0.64 € |
| Spread | 0.05 € |
| Spread % | 4.76% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
87.73
USD
Average target price
96.46
USD
Spread / Average Target
+9.95%
- Stock Market
- Warrants
- Warrant
